References
1. Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med . 2005;352(15):1539-1549.
2. Moss AJ, Hall WJ, Cannom DS, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med . 2009;361(14):1329-1338.
3. Linde C, Ellenbogen K, McAlister FA. Cardiac resynchronization therapy (CRT): clinical trials, guidelines, and target populations.Heart Rhythm . 2012;9(8 Supp):S3-S13.
4. Kirkfeldt RE, Johansen JB, Nohr EA, Jørgensen OD, Nielsen JC. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark. Eur Heart J . 2014;35(18):1186-1194.
5. Freeman JV, Wang Y, Curtis JP, Heidenreich PA, Hlatky MA. The relation between hospital procedure volume and complications of cardioverter-defibrillator implantation from the implantable cardioverter-defibrillator registry. J Am Coll Cardiol . 2010;56(14):1133-1139.
6. Udo EO, Zuithoff NP, van Hemel NM, et al. Incidence and predictors of short- and long-term complications in pacemaker therapy: the FOLLOWPACE study. Heart Rhythm . 2012;9(5):728-735.
7. Mond HG, Irwin M, Ector H, Proclemer A. The world survey of cardiac pacing and cardioverter-defibrillators: calendar year 2005 an International Cardiac Pacing and Electrophysiology Society (ICPES) project. Pacing Clin Electrophysiol . 2008;31(9):1202-1212.
8. Alt E, Volker R, Blomer H. Lead fracture in pacemaker patients.Thorac Cardiov Surg. 1987;35(2):101-104.
9. Magney JE, Flynn DM, Parsons JA, et al. Anatomical mechanisms explaining damage to pacemaker leads, defibrillator leads, and failure of central venous catheters adjacent to the sternoclavicular joint.Pacing Clin Electrophysiol. 1993;16(3 Pt 1):445-457.
10. Rizal A, Ruspiono E, Putri DH. Intermittent pacemaker malfunction caused by continuous compression of the lead by the clavicle (subclavian crush syndrome). Eur J Case Rep Intern Med. 2020;7(8):001684.
11. Kumar A, Ladia V, Abrich V, Scott L. A case of LV lead fracture in submuscular implant: identify and prevent lead fracture. JACC Case Rep . 2019;1(3):306-310.
12. Atti V, Turagam MK, Garg J, et al. Subclavian and axillary vein access versus cephalic vein cutdown for cardiac implantable electronic device implantation: a meta-analysis. JACC Clin Electrophysiol . 2020;6(6):661-671.
13. Zucchelli G, Bongiorni MG, Di Cori A, et al. Cardiac resynchronization therapy after coronary sinus lead extraction: feasibility and mid-term outcome of transvenous reimplantation in a tertiary referral centre. Europace. 2012;14(4):515-521.
14. Burger H, Ziegelhoeffer T, Doll KN. Device therapy of rhythm disorders. In: Ziemer G, Haverich A, editors. Cardiac surgery: operations on the heart and great vessels in dults and children. Berlin/Heidelberg: Springer Verlag . 2017. p. 965-994.
15. Burger H, Pecha S, Hakmi S, et al. Five-year follow-up of transvenous and epicardial left ventricular leads: experience with more than 1000 leads. Interact Cardiovasc Thorac Surg. 2020;30:74-80.
16. Mair H, Sachweh J, Meuris B, et al. Surgical epicardial left ventricular lead versus coronary sinus lead placement in biventricular pacing. Eur J Cardiothorac Surg . 2005;27(2):235-242.
17. McAloon CJ, Anderson BM, Dimitri W, et al. Long-term follow-up of isolated epicardial left ventricular lead implant using a minithoracotomy approach for cardiac resynchronization therapy.Pacing Clin Electrophysiol. 2016;39:1052-1060.